1-9 of 9
Yu ABE, MD
Close
Sort by
Journal Articles

Efficacy of Modified Vrd-Lite for Transplant Ineligible Multiple Myeloma

Mizuki Ogura, MDPhD, Tadao Ishida, MDPhD, Moe Nomura, Hirofumi Irita, Junichiro Nashimoto, Kota Sato, MDPhD, Kanji Miyazaki, MDPhD, Yu Abe, MD, Nobuhiro Tsukada, MDPhD, Kenshi Suzuki, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-143459
Published: 2020
Journal Articles

The Clinical Features of Multiple Myeloma with AL Amyloidosis

Junichiro Nashimoto, Moe Nomura, Hirofumi Irita, Kota Sato, MDPhD, Kanji Miyazaki, MDPhD, Mizuki Ogura, MDPhD, Yu Abe, MD, Nobuhiro Tsukada, MDPhD, Tadao Ishida, MDPhD, Kenshi Suzuki, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10.
https://doi.org/10.1182/blood-2020-142362
Published: 2020
Journal Articles

Retrospective Analysis of the Efficacy and Safety of Modified Bortezomib-Lenalidomide-Dexamethasonelite (modified RVD-lite) Therapy for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Kiyoshi Okazuka, MD, Tadao Ishida, MDPhD, Junichiro Nashimoto, MD, Takao Yogo, MD, Kanji Miyazaki, MD, Kota Sato, MDPhD, Yui Uto, MD PhD, Mizuki Ogura, MDPhD, Yumiko Yoshiki, MDPhD, Yu ABE, MD, Nobuhiro Tsukada, MDPhD, Kenshi Suzuki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1961.
https://doi.org/10.1182/blood-2018-99-112294
Published: 2018
Journal Articles

Phase II Study of the Bortezomib-Melphalan-Prednisolone Induction Therapy Followed By Lenalidomide-Plus-Dexamethasone Consolidation and Lenalidomide Maintenance in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma (CANDLE trial)

Tadao Ishida, MD, Shuji Ozaki, MD PhD, Hideo Kimura, MD PhD, Koumei Kubo, MD, Kazutaka Sunami, MD PhD, Naoki Takezako, MD PhD, Hiroyuki Fujita, MD PhD, Toshiaki Hayashi, MD PhD, Toru Kiguchi, MD PhD, Takeshi Kobayashi, MD, Satoshi Yamamoto, MD PhD, Hiroyuki Takamatsu, MD PhD, Hiroshi Kosugi, MD PhD, Kensuke Ohta, MD PhD, Rika Sakai, MD PhD, Hiroshi Handa, MD PhDChief Division, Takashi Hisatomi, MD PhD, Yu Abe, MD, Ko Sasaki, MD PhD, Eijiro Omoto, MD PhD, Hirokazu Murakami, MDPhDProf, Kazuyuki Shimizu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3121.
https://doi.org/10.1182/blood.V130.Suppl_1.3121.3121
Published: 2017
Journal Articles

Retrospective Analysis of High-Dose Melphalan and Autologous Stem Cell Transplantation for Systemic Light-Chain Amyloidosis: A Single Center 63 Cases

Kiyoshi Okazuka, MD, Nobuhiro Tsukada, Kota Sato, MD, Kanji Miyazaki, Yumiko Yoshiki, Yu Abe, MD, Tadao Ishida, MD, Kenshi Suzuki
Journal: Blood
Blood (2017) 130 (Supplement 1): 4542.
https://doi.org/10.1182/blood.V130.Suppl_1.4542.4542
Published: 2017
Journal Articles

B Cell-Derived Induced Pluripotent Stem Cells Are Useful for Determining the Cellular Origin of Abnormal B Cells in Multiple Myeloma

Aki Yanagi, Fumihiko Kawamura, MS, Makoto Inaki, PhD, Atsushi Katafuchi, PhD, Yukari Yanai, MS, Yu Abe, MD, Naohiro Tsuyama, PhD, Misaki Sugai, BS, Mitsunori Higuchi, MD PhD, Satoshi Muto, MD PhD, Takumi Yamaura, MD, Hiroyuki Suzuki, MD PhD, Hideyoshi Noji, MD PhD, Shinichi Suzuki, MD PhD, Yoshida A Mitsuaki, PhD, Megumi Sasatani, PhD, Kenji Kamiya, MD PhD, Masafumi Onodera, MD PhD, Akira Sakai, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1808.
https://doi.org/10.1182/blood.V130.Suppl_1.1808.1808
Published: 2017
Journal Articles

Difference of Treatment Outcomes in AL Amyloidosis and Multiple Myeloma with / without Translocation (11;14)

Kenshi Suzuki, Miho Kasuga, trainee, Kanji Miyazaki, MD, Sohsuke Meshitsuka, MD, Yu ABE, MD, Yumiko Yoshiki, MD PhD, Nobuhiro Tsukada, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4224.
https://doi.org/10.1182/blood.V126.23.4224.4224
Published: 2015
Journal Articles

Discovery Research On the Effects of Continuous Administration of Bortezomib Maintenance Therapy to Treat Patients with Relapsed and Refractory Multiple Myeloma - Analysis of Background Factors That Affect the Continuity of Therapy-

Kenshi Suzuki, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yu Abe, MD, Rieko Sekine, MD, PhD, Yasunori Nakagawa, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1866.
https://doi.org/10.1182/blood.V120.21.1866.1866
Published: 2012
Journal Articles

Sucessful Management of Pregnancy and Remission-Induction of a Patient with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) by Means of Imatinib Mesilate and HyperCVAD.

Toshiya Suzuki, MD, Yu Abe, MD, Yuki Mori, MD, Yasunori Nakagawa, MD, Keiko Saito, MD, Yoko Matsumoto, MD, Akito Miyauchi, MD, Mitsuhiro Sugimoto, MD, Kenshi Suzuki
Journal: Blood
Blood (2007) 110 (11): 4327.
https://doi.org/10.1182/blood.V110.11.4327.4327
Published: 2007